GP-31502

N/A

Report date: 2024/11/21 15:14:15
NME

Base Information

Drug NameGP-31502
Drug Alias NameGP-31502
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNucleotide reverse transcriptase inhibitors
TargetsNucleotide reverse transcriptase
Therapy Area/IndicationsHepatitis BHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Gritpharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Gritpharma Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis BHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A